Pacer Advisors Inc. Reduces Stock Position in Encompass Health Corporation $EHC

Pacer Advisors Inc. cut its stake in Encompass Health Corporation (NYSE:EHC) by 93.1% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,948 shares of the company’s stock after selling 160,088 shares during the quarter. Pacer Advisors Inc.’s holdings in Encompass Health were worth $1,156,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in EHC. WPG Advisers LLC raised its stake in Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock valued at $34,000 after buying an additional 137 shares during the last quarter. Flagship Harbor Advisors LLC bought a new stake in shares of Encompass Health in the fourth quarter worth $37,000. Assetmark Inc. increased its position in Encompass Health by 89.6% during the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock valued at $44,000 after acquiring an additional 215 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its position in Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock valued at $46,000 after acquiring an additional 362 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new position in Encompass Health in the fourth quarter valued at about $55,000. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Wall Street Zen downgraded Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, June 26th. Barclays lifted their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research note on Thursday. UBS Group upped their price objective on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday. Finally, TD Cowen assumed coverage on Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $146.57.

Encompass Health Trading Up 0.1%

Encompass Health stock opened at $125.39 on Monday. The company has a current ratio of 1.19, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The firm has a market capitalization of $12.44 billion, a price-to-earnings ratio of 20.42, a P/E/G ratio of 2.52 and a beta of 0.72. The firm has a 50 day moving average of $106.91 and a 200 day moving average of $104.62.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The firm had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.57 billion. During the same period in the prior year, the company posted $1.40 earnings per share. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts predict that Encompass Health Corporation will post 6.07 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.21 dividend. The ex-dividend date is Thursday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 12.38%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.